Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7802]

Engineering T cells could be an effective immunotherapy option for leukaemia

Engineering T cells could be an effective immunotherapy option for leukaemia

Discovery lays the foundation to expand personalised chemotherapy for leukaemia patients

Discovery lays the foundation to expand personalised chemotherapy for leukaemia patients

Study finds mechanism by which obesity promotes pancreatic and breast cancer

Study finds mechanism by which obesity promotes pancreatic and breast cancer

A potential therapy for the most aggressive type of lung cancer in preclinical models

A potential therapy for the most aggressive type of lung cancer in preclinical models

Adenovirus dampens host DNA damage response - implications for control and cancer therapy

Adenovirus dampens host DNA damage response - implications for control and cancer therapy

Plant extract shows promise in treating pancreatic cancer

Plant extract shows promise in treating pancreatic cancer

New test could help select the best treatment for bowel cancer patients

New test could help select the best treatment for bowel cancer patients

NHS cancer waiting times show improvement but third of hospital trusts missing referral-to-treatment target

NHS cancer waiting times show improvement but third of hospital trusts missing referral-to-treatment target

Enhanced antitumour activity found for combination of check-point inhibitors durvalumab and tremelimumab in NSCLC

Enhanced antitumour activity found for combination of check-point inhibitors durvalumab and tremelimumab in NSCLC

UK cancer drugs fund consultation: Cancer Research UK reacts

UK cancer drugs fund consultation: Cancer Research UK reacts

More from ecancer